In lung cancer, IGF2BP3 has been reported to have the ability to regulate the alternative splicing of Pyruvate kinase M (PKM), suggesting that IGF2BP3 may play a role in regulating glucose metabolism reprogramming [22]. This evidence concerns the gene IGF2BP3 and lung cancer.